Wspólnotowy Serwis Informacyjny Badan i Rozwoju - CORDIS

FP7

EXALT

Project reference: 602515
Funded under

"Proposal to assess an innovative Immunotherapy, based on a thioredox peptide antigen, in a Phase I Trial for Type-1 Diabetes"

From 2014-02-01 to 2019-01-31, ongoing project

Project details

Total cost:

EUR 8 639 831,39

EU contribution:

EUR 6 000 000

Coordinated in:

France

Call for proposal:

FP7-HEALTH-2013-INNOVATION-1See other projects for this call

Funding scheme:

CP-FP - Small or medium-scale focused research project

Objective

Related information

Coordinator

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France

EU contribution: EUR 556 641,74


RUE DE TOLBIAC 101
75654 PARIS
France
Administrative contact: Lyddie Laaland
Tel.: +33140784935
Fax: +33140784998
E-mail

Participants

IMCYSE SA
Belgium

EU contribution: EUR 3 852 000,26


RUE DU COLLEGE 12
5000 NAMUR
Belgium
Administrative contact: Jérôme Bollue
Tel.: +3226335651
Fax: +3226531438
E-mail
GlaxoSmithKline Biologicals S.A
Participation ended
Belgium

EU contribution: EUR 285 402,5


Rue de l’Institut
1330 Rixensart
Belgium
Administrative contact: Philippe Denoel
Tel.: +3226564032
E-mail
HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Germany

EU contribution: EUR 427 892,5


Ingolstaedter Landstrasse 1
85764 NEUHERBERG
Germany
Administrative contact: Juergen Ertel
Tel.: +49 89 3187 3022
Fax: +49 89 3187 3866
E-mail
QUEEN MARY UNIVERSITY OF LONDON
United Kingdom

EU contribution: EUR 504 892


327 MILE END ROAD
E1 4NS LONDON
United Kingdom
Administrative contact: Greg Dow
Tel.: +442078822569
Fax: +442078827276
E-mail
INSERM - TRANSFERT SA
France

EU contribution: EUR 373 171


Rue Watt 7
75013 PARIS
France
Administrative contact: Louis Jammayrac
Tel.: +33155030100
Fax: +33155030160
E-mail

Subjects

Life Sciences
Record Number: 110445 / Last updated on: 2015-08-27